Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years

摘要

Objective: This study aimed to assess attainment of genetic height potential after long-term growth hormone (GH) treatment in GH-naive children diagnosed with isolated growth hormone deficiency (IGHD), multiple pituitary hormone deficiency (MPHD), born small for gestational age (SGA), or idiopathic short stature (ISS) enrolled in the American Norditropin (R) Studies: Web-enabled Research (ANSWER) Program.